Stonebridge Capital Management Inc Amgen Inc Transaction History

Stonebridge Capital Management Inc

  • $234 Million
  • Q2 2024

A detailed history of Stonebridge Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Stonebridge Capital Management Inc holds 2,336 shares of AMGN stock, worth $773,893. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,336
Previous 2,471 5.46%
Holding current value
$773,893
Previous $703,000 3.84%
% of portfolio
0.31%
Previous 0.31%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024
SELL
$262.75 - $319.31 $35,471 - $43,106
-135 Reduced 5.46%
2,336 $730,000
Q4 2021

Jan 05, 2022
SELL
$198.88 - $227.6 $89,694 - $102,647
-451 Reduced 15.43%
2,471 $556,000
Q3 2021

Oct 07, 2021
SELL
$212.27 - $248.7 $21,227 - $24,870
-100 Reduced 3.31%
2,922 $621,000
Q4 2020

Jan 06, 2021
BUY
$216.38 - $257.67 $8,655 - $10,306
40 Added 1.34%
3,022 $695,000
Q3 2020

Dec 11, 2020
BUY
$234.65 - $260.95 $14,079 - $15,657
60 Added 2.05%
2,982 $758,000
Q1 2020

May 20, 2020
BUY
$182.24 - $241.7 $18,224 - $24,170
100 Added 3.54%
2,922 $592,000
Q3 2019

Oct 02, 2019
SELL
$174.11 - $208.62 $4,352 - $5,215
-25 Reduced 0.88%
2,822 $546,000
Q2 2018

Jul 06, 2018
SELL
$166.05 - $186.51 $7.69 Million - $8.63 Million
-46,295 Reduced 94.21%
2,847 $533,000
Q1 2018

Apr 16, 2018
BUY
$169.43 - $198.0 $7.85 Million - $9.17 Million
46,320 Added 1641.39%
49,142 $8.58 Million
Q4 2017

Jan 29, 2018
BUY
$168.79 - $188.59 $476,325 - $532,200
2,822
2,822 $522,000

Others Institutions Holding AMGN

# of Institutions
2,959
Shares Held
402M
Call Options Held
6.59M
Put Options Held
6.61M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $177B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stonebridge Capital Management Inc Portfolio

Follow Stonebridge Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email